CARDIOME PHARMA CORP - COM NO PAR (CRME)

CUSIP: 14159U301

Q4 2016 13F Holders as of 31 Dec 2016

Type / Class
Equity / COM NO PAR
Total 13F shares
19,489,549
Share change
-293,823
Total reported value
$53,789,000
Price per share
$2.76
Number of holders
31
Value change
-$1,052,490
Number of buys
10
Number of sells
14

Quarterly Holders Quick Answers

What is CUSIP 14159U301?
CUSIP 14159U301 identifies CRME - CARDIOME PHARMA CORP - COM NO PAR in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CARDIOME PHARMA CORP - COM NO PAR (CRME) as of Q4 2016

As of 31 Dec 2016, CARDIOME PHARMA CORP - COM NO PAR (CRME) was held by 31 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 19,489,549 shares. The largest 10 holders included WESTFIELD CAPITAL MANAGEMENT CO LP, PUTNAM INVESTMENTS LLC, Stonepine Capital Management, LLC, Clough Capital Partners L P, Tamarack Advisers, LP, Rock Springs Capital Management LP, AlphaOne Investment Services, LLC, SABBY MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC, and CREDIT SUISSE AG/. This page lists 31 institutional shareholders reporting positions in this security for the Q4 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.